ETR:HNL

Dr. Hönle (HNL) Stock Price, News & Analysis

€20.00
-0.20 (-0.99%)
(As of 04/24/2024 ET)
Today's Range
€20.00
€20.10
50-Day Range
€15.35
€20.20
52-Week Range
€15.00
€24.50
Volume
5,275 shs
Average Volume
N/A
Market Capitalization
$121.20 million
P/E Ratio
N/A
Dividend Yield
1.00%
Price Target
N/A
HNL stock logo

About Dr. Hönle Stock (ETR:HNL)

Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.

HNL Stock Price History

HNL Stock News Headlines

Dr. Hönle (ETR:HNL) Trading Up 1.3%
How to camouflage a factory of 53,000 workers
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
Dr. Susan N. Mizuno
Free Things To Do in Honolulu - Oahu
How to camouflage a factory of 53,000 workers
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
Dr Hoenle AG (HNL.HM)
Dr Hoenle AG HNL
Dr. Hönle AG (HNL.F)
Getting Around Honolulu - Oahu
Dr. Lyle T. Tenjoma
Dr. Andrew Inaba
Dr. Weilin Bono
Dr. John Ha
Dr. James S. Tamai
Dr. Peter Kyriakakis
Dr. Michael R. Umaki
Dr. Samuel M. Ishimura
See More Headlines
Receive HNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Electrical Equipment & Parts
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
581
Year Founded
N/A

Profitability

Net Income
$-13,830,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$102.56 million
Cash Flow
€1.03 per share
Book Value
€15.38 per share

Miscellaneous

Free Float
N/A
Market Cap
$122.41 million
Optionable
Not Optionable
Beta
1.48
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Franz Richter (Age 69)
    Chairman of the Management Board, MD & CEO
    Comp: $374.4k
  • Peter Weinert
    Head of Investor Relations

HNL Stock Analysis - Frequently Asked Questions

How have HNL shares performed in 2024?

Dr. Hönle's stock was trading at €17.50 at the beginning of the year. Since then, HNL stock has increased by 14.3% and is now trading at €20.00.
View the best growth stocks for 2024 here
.

Is Dr. Hönle a good dividend stock?

Dr. Hönle (ETR:HNL) pays an annual dividend of €0.20 per share and currently has a dividend yield of 1.09%.

This page (ETR:HNL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners